self-assembling vaccine (HaloVax)

N/A

Report date: 2025/01/26 15:37:15

Base Information

Drug Nameself-assembling vaccine (HaloVax)
Drug Alias NameCOVID-19 vaccine (HaloVax)SARS-CoV-2 vaccine (HaloVax)self-assembling vaccine (HaloVax)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Ovarian NeoplasmsNeoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHaloVax LLC
China Registration ClassN/A

Develop Information

Active CompaniesHaloVax LLC
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Ovarian NeoplasmsPapillomavirus Infections
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A